𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peroxisome proliferator-activated receptor (PPAR)-γ ligand inhibits the progression of pancreatic fibrosis in vivo and profibrogenic action in pancreatic myofibroblast

✍ Scribed by Kyoko Shimizu; Shoko Hisada; Keiko Shiratori; Makio Kobayashi; Naoaki Hayashi

Book ID
119429408
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
193 KB
Volume
120
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ligands for peroxisome proliferator-acti
Ligands for peroxisome proliferator-activated receptor γ inhibit growth of pancreatic cancers both in vitro and in vivo
✍ Atsushi Itami; Go Watanabe; Yutaka Shimada; Yosuke Hashimoto; Junichiro Kawamura 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

Peroxisome proliferator-activated receptor ␥ (PPAR␥) is expressed largely in adipose tissues and plays an important role in adipocyte differentiation. Several studies have recently shown that ligands of PPAR␥ could lead to growth inhibition in some malignancies. In our study, we focused on pancreati

Differential anti-inflammatory propertie
Differential anti-inflammatory properties of peroxisome proliferator-activated receptors (PPAR) α and γ in experimental pancreatitis
✍ Thomas Griesbacher; Veronika Pommer; Rufina Schuligoi; Bernhard A Peskar 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 78 KB

Perfluorooctanoic acid (PFOA) has anti-inflammatory effects in models of cutaneous inflammation, possibly via activation of PPAR-α and PPAR-γ. We have therefore investigated whether PFOA has similar effects in a model of acute oedematous pancreatitis and whether such effects could be explained by ag